2021, Number 2
Clinical cases on conservative treatment of chronic subdural hematoma
Language: Spanish
References: 11
Page:
PDF size: 262.22 Kb.
ABSTRACT
Introduction: Chronic subdural hematoma is one of the most common clinical entities in everyday neurosurgical practice, which incidence and prevalence increase considerably with age. Conservative treatment can be very useful in many patients.Objective: To show that the exclusive pharmacological management of this condition can be considered in many patients.
Clinical cases: Two elderly patients attended at the neurosurgery service are presented with a diagnosis of chronic subdural hematoma. They were treated only with drugs.
Conclusions: The final result was the reabsorption of the subdural collections, which was proven by imaging studies.
REFERENCES
Edlmann E, Giorgi-Coll S, Whitfield PC, Carpenter K LH, Hutchinson PJ. Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy. Journal of Neuroinflammation. 2017 [acceso: 29/08/2019]; 14(108):[aprox. 4 p.]. Disponible en: Disponible en: https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-017-0881-y
Holl DC, Volovici V, Dirven CMF, Peul WC, van Kooten F, Jellema K. Pathophysiology and Nonsurgical Treatment of Chronic Subdural Hematoma: From Past to Present to Future. World Neurosurg. 2018 [acceso: 29/08/2019];116: [aprox.8 p.]. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/29772364
Peng D, Zhu Y. External drains versus no drains after burr-hole evacuation for the treatment of chronic subdural haematoma in adults Format: Abstract Send to. Cochrane Database Syst Rev. 2016 [acceso: 29/08/2019]; 31(8):[aprox. 4 p.]. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/27578263
Dziedzic TA, Kunert P, Marchel A. Clinical Course and Results of Surgery for Chronic Subdural Hematomas in Patients on Drugs Affecting Hemostasis. J Korean Neurosurg Soc. 2017 [acceso: 22/05/2020]; 60(2):232‐8. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365289/pdf/jkns-60-2-232.pdf
Christopher E, Poon M TC, Glancz LJ, Hutchinson PJ, Kolias AG, Brennan PM. Outcomes following surgery in subgroups of comatose and very elderly patients with chronic subdural hematoma. Neurosurg Rev. 2019 [acceso: 29/08/2019]; 42(2):[aprox.2 p.]. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/29679178
Chung Chan DY, Ming Chan DT, David Sun TF, Chi Ping Ng S, Chu Wong GK, Sang Poon W. The use of atorvastatin for chronic subdural haematoma: a retrospective cohort comparison study. British. Journal of Neurosurgery. 2017 [acceso: 29/08/2019]; 31(1):[aprox.5 p.]. Disponible en: https://doi.org/10.1080/02688697.2016.1208806
Iorio-Morin C, Blanchard J, Richer M, Mathieu D. Tranexamic Acid in Chronic Subdural Hematomas (TRACS): study protocol for a randomized controlled trial. Trials. 2016 [acceso 22/05/2020]; 17(1):235. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4857422/pdf/13063_2016_Article_1358.pdf
Chacín González JP, Reyes Graterol EO, García Oduber SM. Complications associated to tranexamic acid in the surgical drainage of subdural hematoma. Rev. Chil. Neurocirugía. 2018 [acceso 22/05/2020]; 44:121-127. Disponible en: Disponible en: https://www.neurocirugiachile.org/wp-content/uploads/2018/11/Chacin_p121_v44n2_2018.pdf